查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808443

生物樣本庫市場（按產品、生物樣本庫類型、應用和最終用戶分類）—2025-2030 年全球預測

Biobanking Market by Offering, Biobank Type, Sample Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年生物銀行市場價值將達729.8億美元，2025年成長至813.7億美元，複合年成長率為11.80%，到2030年將達到1425.3億美元。

主要市場統計數據
基準年2024年 729.8億美元
預計2025年 813.7億美元
預計2030年 1425.3億美元
複合年成長率（%） 11.80%

創新的生物銀行平台將推動全球科學界在疾病研究和個人化醫療方面的突破

生物樣本庫已成為現代生命科學研究的基礎基礎設施，在保存珍貴生物檢體的同時，也能獲得重要的相關數據。隨著精準醫療範圍的不斷擴大，越來越多的研究依賴管理完善的樣本庫來深入了解疾病機制和治療反應。樣本完整性與資料品質之間的這種共生關係，凸顯了強大的生物銀行系統的戰略重要性，該系統能夠將先進的保存技術與全面的資訊學功能無縫整合。

模式轉移正在推動生物銀行：從傳統的儲存設施到將影響未來研究的整合資料驅動平台。

過去十年，技術創新引領生物銀行經歷了數次變革。最初，生物樣本庫專注於實體儲存基礎設施，如今已發展成為一個集整合技術於一體的生態系統，旨在提高效率和擴充性。自動化檢體搜尋系統減少了人為錯誤，人工智慧驅動的分析技術也開始揭示檢體利用的模式，為策略決策提供參考。

2025年美國關稅調整評估；擴大成本結構與供應鏈動態影響生物銀行營運與全球合作模式

隨著美國提案的2025年關稅調整，全球供應鏈正在重新調整，生物樣本庫產業面臨複雜的挑戰與機會。一方面，進口耗材和設備關稅的提高可能會增加營運成本，迫使相關人員重新評估籌資策略。另一方面，國內製造合作夥伴可能會面臨需求激增，促使本地生產能力的擴張，並促進研究機構和供應商之間的新合作。

全面的細分洞察揭示了涵蓋儀器、服務、軟體解決方案、檢體類型、應用和最終用戶的多種生物銀行市場促進因素

對生物銀行產品的檢查揭示了一個三部分結構，包括有形基礎設施、專業服務和數位管理平台。在產品類型中，先進的設備和消耗品構成了檢體儲存的支柱。自動化儲存系統簡化了樣本檢索，而低溫儲存設備保持了超低溫完整性。培養箱、離心機、冰箱和冷凍庫等測試關鍵設備是這些核心資產的補充，專門設計的運輸和包裝裝置可以在運輸過程中保護檢體。與這些工具相輔相成的是一系列為實現最佳樣本活力和法規遵從性而設計的消耗品。同時，基於服務的模型已經發展到可以解決生物銀行工作流程的全部範圍，包括計劃通訊協定中嵌入的同意和法律規範、先進的資料管理和生物資訊解決方案、端到端樣本採集、處理和儲存服務，以及確保無縫監管鏈的專用運輸和物流網路。除了這些實體和服務組件之外，軟體平台還提供集中監督和強大的實驗室資訊管理系統和分析儀表板，可匯總元元資料以提供策略決策資訊。

戰略區域視角突顯了美洲、歐洲、中東和非洲以及亞太地區在不斷擴大的生物銀行系統中的趨勢和成長槓桿

在北美和拉丁美洲，成熟的研究中心持續推動生物銀行創新。這些先進的設施採用尖端的低溫運輸技術和全面的資料管理基礎設施，並得到公共和私人資金的大力支持。這種成熟的環境促進了學術中心、生技公司和監管機構之間的合作網路，致力於推動精準醫療舉措。同時，拉丁美洲的新興市場正在加大對生物樣本庫能力的投資，以支持區域人口研究並應對地方性健康挑戰。因此，戰略夥伴關係和技術轉移協議變得至關重要，使相關人員能夠利用區域樣本的多樣性，同時保持全球品質標準。

領先的生物銀行創新者推動技術進步；商業策略和合資企業改變檢體儲存、分析和物流解決方案

產業領導者正透過在自動化、資訊科技和策略聯盟方面的有針對性的投資，展現出推動生物銀行發展的明確承諾。例如，一家知名設備供應商正在整合機器人技術和雲端基礎監控系統，以增強低溫儲存自動化，並實現即時警報和預測性維護。分子樣本製備專家擴展了其產品組合，納入了全面的數據分析解決方案，以最佳化工作流程並簡化監管報告。這些技術供應商正在為檢體完整性和操作透明度樹立新的標準。

為生物銀行相關人員提供可操作的藍圖，以提高營運效率、促進創新、加強監管合規性並擴大策略聯盟

為了在不斷發展的生物銀行領域保持競爭優勢，產業領導者應優先採用先進的自動化和數位化技術。部署機器人儲存和搜尋系統，並結合集中式分析平台，可提高吞吐量，同時最大限度地減少人為錯誤。此外，整合機器學習工具來預測設備維護並簡化樣本追蹤，可以增強營運彈性。

整合定性和定量方法的強大調查方法，原始資料收集和嚴格的檢驗過程，以確保可靠性和深度

本報告背後的調查方法結合了定性和定量分析，旨在提供全面且客觀的見解。初步的二次研究涵蓋了廣泛的學術文獻、行業出版物和監管指南，旨在對當前的生物銀行實踐和新興趨勢建立基礎性的理解。這項案頭研究促成了主要研究方法和訪談通訊協定的發展。

生物銀行發展研究總結強調策略重要性：協作創新和麵向未來的解決方案塑造研究格局

隨著生物銀行領域的不斷發展，它仍然是轉化研究和精準醫療工作的基石。先進儲存技術、資訊平台和服務導向模式的整合正在重塑傳統的工作流程，實現更有效率、更可靠的檢體管理。此外，虛擬儲存庫和分散式網路的整合正在拓寬合作研究的視野，並促進整個研究界的創新。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 擴展分佈式生物庫網路以支援遠端臨床試驗樣本採集
  • 人工智慧在高通量綜合生物庫中的預測品管
  • 實施基於區塊鏈的可追溯系統，以安全管理生物庫樣本保管鏈
  • 精準醫學研究對個別樣本儲存解決方案的需求日益成長
  • 生物樣本庫與製藥公司建立策略夥伴關係關係，加速生物標記的發現
  • 簡化跨境合作的監理協調舉措

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章：2025年美國關稅的累積影響

第 8 章 生物樣本庫市場（按產品提供）

  • 產品
    • 生物庫設備
      • 自動樣品儲存系統
      • 低溫儲存系統
      • 培養箱和離心機
      • 冰箱和冷凍庫
      • 樣品運輸和包裝單元
    • 耗材
  • 服務
    • 同意和監管合規服務
    • 數據管理和生物資訊學
    • 採樣和處理服務
    • 樣品儲存服務
    • 樣品運輸及物流
  • 軟體

第9章生物樣本庫市場（依生物樣本庫類型）

  • 物理生物樣本庫
  • 虛擬生物庫

第 10 章。生物樣本庫市場（按樣本類型）

  • 血
    • 電漿
    • 血清
    • 全血
  • 細胞
  • DNA/RNA
  • 組織

第 11 章 生物樣本庫市場（按應用）

  • 診斷和治療
  • 藥物研發與臨床研究

第 12 章 生物樣本庫市場（按最終用戶）

  • 學術研究機構
  • 合約研究組織（CRO）
  • 政府和公共衛生機構
  • 醫院和臨床實驗室
  • 製藥和生物技術公司

第 13 章：美洲生物銀行市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第14章歐洲、中東和非洲的生物銀行市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太生物庫市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Avantor, Inc.
    • Thermo Fisher Scientific Inc.
    • ASKION GmbH
    • Azenta Life Sciences, Inc.
    • BioKryo
    • BioLife Solutions, Inc.
    • Charles River Laboratories International, Inc.
    • Cryoport Systems, LLC
    • Cureline, Inc.
    • FIND
    • Firalis Molecular Precision
    • Greiner Bio-One International GmbH
    • Hamilton Company
    • LGC Biosearch Technologies
    • Merck KGaA
    • PHC Corporation
    • Qiagen NV
    • Sampled
    • Sopachem BV
    • SPT Labtech Ltd
    • STEMCELL Technologies Inc.
    • Taylor-Wharton
    • Tecan Trading AG
    • US Biolab Corporation, Inc.
    • VigiSolvo

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-961BA04A2DC3

The Biobanking Market was valued at USD 72.98 billion in 2024 and is projected to grow to USD 81.37 billion in 2025, with a CAGR of 11.80%, reaching USD 142.53 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 72.98 billion
Estimated Year [2025] USD 81.37 billion
Forecast Year [2030] USD 142.53 billion
CAGR (%) 11.80%

Innovative Biobanking Foundations Driving Breakthroughs in Disease Research and Personalized Healthcare Across Global Scientific Communities

Biobanks have emerged as foundational infrastructures in modern life sciences research, preserving precious biological specimens while capturing critical associated data. As the scope of precision medicine expands, researchers increasingly rely on well-curated sample repositories to unlock insights into disease mechanisms and therapeutic responses. This symbiotic relationship between sample integrity and data quality underscores the strategic importance of robust biobanking systems that seamlessly integrate advanced storage technologies with comprehensive informatics capabilities.

In recent years, interdisciplinary collaborations have accelerated innovation across the biobanking landscape. Cutting-edge cryogenic storage platforms now interface with digital management solutions, enabling real-time monitoring of specimen viability and metadata analytics. Consequently, research institutions and industry stakeholders can mitigate variability, enhance reproducibility and accelerate discovery cycles. These technological synergies have redefined best practices, elevating biobanks from passive repositories to dynamic research hubs.

Looking ahead, evolving regulatory frameworks and ethical considerations will further shape the trajectory of biobanking operations. With an emphasis on consent management, data privacy and interoperability standards, biobanks are poised to become pivotal enablers of decentralized clinical trials and population-scale studies. This introductory overview sets the stage for a deeper exploration of the transformative trends driving the next frontier of biobanking excellence.

Global health initiatives are increasingly leveraging biobanking networks to support large-scale population studies and accelerate responses to public health crises. By integrating multi-omic datasets with patient demographics, researchers can identify biomarkers and therapeutic targets with greater precision. Additionally, partnerships between academic consortia, healthcare providers and private sector innovators have intensified, fostering knowledge exchange and accelerating translational pipelines. Consequently, the role of biobanks extends beyond preservation; they are now instrumental in orchestrating collaborative research efforts that span continents and disciplines, ultimately contributing to more resilient healthcare systems and improved patient outcomes.

Paradigm Shifts Catalyzing the Evolution of Biobanking from Conventional Storage Facilities to Integrated Data-Driven Platforms Shaping Future Research

Innovation has propelled biobanking through several transformative shifts over the last decade. Initially focused on physical storage infrastructure, the discipline now embraces an ecosystem of integrated technologies that promote efficiency and scalability. Automated sample retrieval systems have reduced manual handling errors, while artificial intelligence-driven analytics have begun to uncover patterns in specimen utilization that inform strategic decision making.

Moreover, the rise of virtual biobanks has redefined traditional paradigms by enabling remote access to digital representations of biological materials. This shift has fostered cross-institutional collaborations, as researchers can now query standardized datasets without logistical constraints. Simultaneously, the emergence of cloud-based platforms has facilitated streamlined data governance, providing secure channels for consent management and multi-modal integration of genomic, clinical and environmental data.

In addition, service-oriented models have gained prominence, with specialized providers offering end-to-end solutions spanning sample collection, processing, storage and transport. This diversification has allowed organizations to tailor biobanking strategies to project-specific requirements, optimizing resource allocation and reducing time to insight. As the biobanking sector continues to mature, these foundational shifts will underpin future innovations and guide sustainable growth across the global research landscape.

Emerging trends in sustainability and environmental responsibility are also reshaping biobanking practices. Institutions are adopting energy-efficient ultra-low temperature freezers and exploring renewable energy integration within cold storage facilities to minimize carbon footprints. In parallel, digital twin models of storage environments enable simulation of energy usage patterns to optimize resource allocation. As a result, biobanks are not only improving operational efficiency but also aligning with corporate social responsibility goals, reinforcing their commitment to sustainable science and long-term viability in a resource-conscious world.

Assessment of United States Tariff Adjustments in 2025 Expanding Cost Structures and Supply Chain Dynamics Impacting Biobanking Operations and Global Collaboration Models

As global supply chains recalibrate in response to the United States' proposed 2025 tariff adjustments, the biobanking community faces a complex set of challenges and opportunities. On one hand, increased duties on imported consumables and equipment could elevate operational costs, prompting stakeholders to reevaluate procurement strategies. On the other hand, domestic manufacturing partners may experience a surge in demand, driving expansion of local production capabilities and fostering new alliances between research institutions and suppliers.

Furthermore, shifting trade policies have underscored the importance of supply chain resilience. In response, biobanks are diversifying vendor portfolios and exploring nearshoring options to mitigate the risk of prolonged lead times and geopolitical disruptions. At the same time, strategic stockpiling of critical reagents and consumables has emerged as a proactive measure to ensure continuity of operations, particularly for long-term cohort studies and high-throughput variant screening projects.

In addition to cost implications, regulatory harmonization efforts are gaining momentum. Collaborative dialogues between public health agencies and industry consortia aim to streamline cross-border logistics, reduce documentation burdens and expedite customs clearance processes. Consequently, the sector can maintain high standards of sample integrity while adapting to evolving trade environments. Taken together, these dynamics will redefine procurement frameworks and operational priorities across the biobanking value chain.

As organizations navigate these tariff-induced cost pressures, many are exploring performance-based contracts with suppliers to achieve negotiated pricing and guarantee supply continuity. Simultaneously, government incentive programs and public-private funding initiatives aim to offset increased duties, offering grants and tax credits for domestic equipment investments. These support mechanisms foster local manufacturing expansion and encourage stakeholders to engage in long-term infrastructure planning.

Comprehensive Segmentation Insights Revealing Diverse Biobanking Market Drivers Spanning Equipment, Services, Software Solutions, Specimen Types, Applications and End Users

An examination of biobanking offerings reveals a tripartite structure encompassing tangible infrastructure, specialized services and digital management platforms. Within the product category, sophisticated equipment and consumables form the backbone of specimen preservation. Automated storage systems streamline sample retrieval while cryogenic storage units maintain ultra-low temperature integrity. Essential laboratory instruments such as incubators, centrifuges, refrigerators and freezers complement these core assets, and purpose-designed transport and packaging units safeguard specimens during transit. Complementing these tools is an array of consumables engineered for optimal sample viability and regulatory compliance. Meanwhile, service-based models have evolved to address the full spectrum of biobanking workflows: consent and regulatory frameworks embedded within project protocols; advanced data management and bioinformatics solutions; end-to-end sample collection, processing and storage services; and dedicated transport and logistics networks that ensure seamless chain of custody. Layered atop these physical and service components, software platforms provide centralized oversight, offering robust laboratory information management systems and analytical dashboards that aggregate metadata to inform strategic decisions.

Diving deeper into biobank typologies, traditional physical repositories coexist with emerging virtual environments. The former emphasizes on-site specimen curation and long-term archiving, whereas the latter leverages digital interfaces and distributed data links to facilitate remote access and collaborative research. This dual approach enables institutions to adapt storage strategies to project demands, balancing in-house capabilities with networked sharing models.

Regarding specimen categories, whole blood and its derivatives-plasma and serum-form a critical segment, alongside discrete cell lines, extracted DNA and RNA preparations, and a diverse array of tissue samples. Each sample type presents unique handling and preservation challenges, driving tailored protocol development.

In terms of application, biobanks support both diagnostics and therapeutics through patient specimen repositories and serve as foundational resources for drug discovery and clinical research initiatives. This breadth of use cases underscores the sector's capacity to bridge translational gaps.

Finally, a wide spectrum of end users relies on these segmented offerings. Academic and research institutions pursue foundational science, whereas contract research organizations prioritize streamlined trial operations. Government and public health agencies demand stringent compliance, clinical laboratories and hospital systems integrate repositories into care pathways, and pharmaceutical and biotechnology companies harness biobanking assets to accelerate pipeline development.

Strategic Regional Perspectives Highlighting Trends and Growth Levers Across Americas, Europe Middle East Africa and Asia-Pacific in the Expanding Biobanking Ecosystem

Throughout the Americas, established research hubs in North America continue to drive innovation in biobanking. Cutting-edge facilities leverage state-of-the-art cold chain technologies and comprehensive data management infrastructures, underpinned by robust funding from public and private sources. This mature environment fosters collaborative networks between academic centers, biotechnology firms and regulatory bodies focused on advancing precision medicine initiatives. At the same time, emerging markets in Latin America are increasingly investing in biobank capabilities to support regional population studies and address endemic health challenges. As a result, strategic partnerships and technology transfer agreements have become pivotal, enabling stakeholders to capitalize on local sample diversity while maintaining global quality standards.

In Europe, Middle East and Africa, a diverse mosaic of biobanking ecosystems is taking shape. European nations benefit from pan-national consortia that harmonize protocols, data privacy regulations and operational benchmarks, creating scalable repositories accessible to multinational research teams. Meanwhile, several Middle Eastern countries are bolstering infrastructure investments to advance national genomics agendas and public health surveillance. Across Africa, partnerships with international research organizations are catalyzing the development of population-scale biobanks aimed at understanding disease dynamics within underrepresented cohorts. Despite challenges related to funding models and logistic complexities, this region presents significant opportunities for collaborative innovation and capacity building.

Asia-Pacific exhibits rapid expansion driven by government-led precision health programs and a burgeoning biotechnology sector. Leading economies such as China, Japan and Australia have established sophisticated biobank networks integrated with hospital systems and research institutes, reinforcing translational research pipelines. In parallel, India and Southeast Asian nations are scaling sample collection and processing capabilities to support large-scale cohort studies. Stakeholders in this region are prioritizing regulatory harmonization, digital transformation of laboratory workflows and localized manufacturing of critical consumables. Consequently, Asia-Pacific is poised to become a strategic growth arena, shaping global biobanking trends and best practices.

Leading Biobanking Innovators Driving Technological Advancements Commercial Strategies and Collaborative Ventures Transforming Sample Storage Analytical and Logistics Solutions

Industry leaders have demonstrated a clear commitment to advancing biobanking through targeted investments in automation, informatics and strategic collaborations. For instance, one prominent instrumentation provider has enhanced cryogenic storage automation by integrating robotics with cloud-based monitoring systems, enabling real-time alerts and predictive maintenance. Another specialist in molecular sample preparation has expanded its portfolio to include comprehensive data analytics solutions that streamline workflow optimization and regulatory reporting. These technology providers are setting new standards for specimen integrity and operational transparency.

Meanwhile, a leading automation firm has deployed high-throughput liquid handling platforms capable of processing thousands of samples per day, reducing manual intervention and accelerating study timelines. An established laboratory systems supplier has fortified its software suite, embedding laboratory information management functionalities that support chain-of-custody tracking, consent management and multi-site collaboration. Complementing these efforts, several emerging biotech companies are focusing on modular cold chain consumables designed to maintain ultra-low temperature stability during long-distance shipments.

Additionally, several agile startups are challenging incumbent players by developing niche solutions such as lab-on-chip sample stabilization and blockchain-based provenance tracking. These disruptive entrants emphasize modularity and interoperability, compelling established companies to accelerate innovation cycles and integrate open-architecture frameworks. This dynamic competitive landscape underscores the value of continuous R&D investments and adaptive business models.

Moreover, strategic partnerships and mergers have reshaped the competitive landscape. Major corporations have acquired niche informatics firms to bolster their end-to-end biobanking offerings, while others have forged alliances with academic consortia to pilot decentralized storage models. These corporate maneuvers underscore a broader trend toward integrated solutions designed to address the diverse needs of research institutions, clinical laboratories and pharmaceutical developers alike.

Actionable Roadmap for Biobanking Stakeholders to Enhance Operational Efficiency Foster Innovation Strengthen Regulatory Compliance and Expand Strategic Collaborations

To maintain a competitive edge in the evolving biobanking arena, industry leaders should prioritize the adoption of advanced automation and digitalization technologies. Implementing robotic storage and retrieval systems, coupled with centralized analytics platforms, can enhance throughput while minimizing human error. In addition, integrating machine learning tools to predict equipment maintenance and streamline sample tracking will reinforce operational resilience.

Concurrently, organizations must reinforce their regulatory and ethical frameworks by establishing transparent consent management processes and adhering to emerging international standards. Developing modular compliance protocols that can be adapted to new jurisdictions will reduce administrative overhead and facilitate cross-border research collaborations.

Fostering partnerships across research institutions, service providers and technology vendors will unlock synergies and accelerate innovation. Joint ventures and consortia can pool resources for large-scale studies, enabling access to diverse specimen collections and sharing best practices in specimen handling and data governance.

Furthermore, procurement strategies should emphasize supply chain diversification and local sourcing of critical equipment and consumables. By cultivating relationships with multiple vendors and exploring nearshoring options, biobanking operations can mitigate the impact of tariff fluctuations and logistical disruptions.

Prioritizing robust cybersecurity measures and data interoperability standards is equally important. Biobanking leaders should establish encrypted data exchanges and adopt universal metadata schemas to facilitate seamless collaboration. This emphasis on secure and harmonized data flows will further strengthen trust among partners and enhance the scalability of cross-institutional research programs.

Finally, continuous skills development remains vital. Investing in targeted training programs for technical staff and data managers will ensure that organizations can effectively leverage new technologies and maintain high standards of sample integrity and data quality.

Robust Research Methodology Integrating Qualitative and Quantitative Approaches Primary Data Collection and Rigorous Validation Processes Ensuring Reliability and Depth

The research methodology underpinning this report combines both qualitative and quantitative approaches to deliver comprehensive and unbiased insights. Initial secondary research involved an extensive review of academic literature, industry publications and regulatory guidelines to establish a foundational understanding of current biobanking practices and emerging trends. This desk research informed the development of primary research instruments and interview protocols.

Primary data collection was conducted through in-depth interviews with leading practitioners, equipment manufacturers, service providers and regulatory experts. These discussions provided nuanced perspectives on operational challenges, technology adoption and strategic priorities. In parallel, an online survey targeted a broad cross-section of end users to capture quantitative data on sample type preferences, storage requirements and budgetary allocations.

Data triangulation was achieved by cross-verifying information from multiple sources, ensuring that findings reflect a consistent and accurate industry narrative. Key metrics and thematic insights were validated through iterative expert reviews, enabling adjustments to interpretation and emphasis based on peer feedback. Statistical analysis techniques, including trend mapping and correlation assessments, further enriched the robustness of the conclusions.

The research methodology also incorporated a thorough review of ethical frameworks and data privacy regulations. Potential limitations related to respondent bias and geographic representation were mitigated through purposive sampling and weighting adjustments. Ethical considerations guided the design of interview questions and data handling protocols, ensuring anonymity and compliance with global human subject research standards.

Overall, the methodology was designed to balance depth and breadth, combining granular field-level observations with high-level trend analysis. This hybrid approach ensures that the resulting strategic recommendations and market insights are both actionable and grounded in empirical evidence.

Concluding Reflections on Biobanking Evolution Emphasizing Strategic Imperatives Collaborative Innovations and Future-Ready Solutions Shaping the Research Landscape

As the biobanking sector continues to evolve, it remains a cornerstone of translational research and precision medicine endeavors. The convergence of advanced storage technologies, informatics platforms and service-oriented models has reshaped traditional workflows, enabling more efficient and reliable specimen management. Moreover, the integration of virtual repositories and decentralized networks has expanded collaborative horizons, fostering innovation across research communities.

Regulatory realignments and tariff dynamics further underscore the need for agile operational strategies. By embracing diversified procurement configurations and strengthening cross-border logistics frameworks, organizations can safeguard supply continuity and maintain high standards of sample viability. Meanwhile, segmentation insights reveal that a comprehensive understanding of product offerings, biobank typologies, specimen categories, application areas and end-user needs is essential for designing tailored solutions that drive scientific progress.

Regional analysis highlights distinct geographical opportunities, from established hubs in North America and Europe to rapidly emerging markets in Asia-Pacific and strategic growth corridors across the Middle East and Africa. Concurrently, leading companies are demonstrating how targeted investments in automation, analytics and strategic partnerships can unlock new value propositions.

Ultimately, thriving biobanking ecosystems will depend on continuous innovation, inclusive governance structures and adaptive business models. Collaborative innovation hubs and public-private consortia will play pivotal roles in translating scientific discoveries into scalable solutions. Embracing a culture of transparency, shared learning and technological agility will be key to sustaining momentum as the field advances.

Looking forward, the path to sustainable biobanking excellence will hinge on balancing operational efficiency with ethical governance, fostering collaborative ecosystems and continuously innovating through technology adoption. These strategic imperatives offer a clear roadmap for stakeholders seeking to advance research capabilities and deliver impactful outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of decentralized biobanking networks to support remote clinical trial sample collection
  • 5.2. Integration of artificial intelligence for predictive quality control in high-throughput biobanking
  • 5.3. Adoption of blockchain-based traceability systems for secure biobank sample chain of custody
  • 5.4. Growing demand for personalized sample storage solutions in precision medicine research
  • 5.5. Strategic partnerships between biobanking organizations and pharmaceutical companies to accelerate biomarker discovery
  • 5.6. Regulatory harmonization initiatives to streamline cross-border biobanking collaborations

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Biobanking Market, by Offering

  • 8.1. Introduction
  • 8.2. Product
    • 8.2.1. Biobanking Equipment
      • 8.2.1.1. Automated Sample Storage Systems
      • 8.2.1.2. Cryogenic Storage Systems
      • 8.2.1.3. Incubators & Centrifuges
      • 8.2.1.4. Refrigerators & Freezers
      • 8.2.1.5. Sample Transport & Packaging Units
    • 8.2.2. Consumables
  • 8.3. Services
    • 8.3.1. Consent & Regulatory Compliance Services
    • 8.3.2. Data Management & Bioinformatics
    • 8.3.3. Sample Collection & Processing Services
    • 8.3.4. Sample Storage Services
    • 8.3.5. Sample Transport & Logistics
  • 8.4. Software

9. Biobanking Market, by Biobank Type

  • 9.1. Introduction
  • 9.2. Physical Biobanks
  • 9.3. Virtual Biobanks

10. Biobanking Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
    • 10.2.1. Plasma
    • 10.2.2. Serum
    • 10.2.3. Whole Blood
  • 10.3. Cells
  • 10.4. DNA/RNA
  • 10.5. Tissue

11. Biobanking Market, by Application

  • 11.1. Introduction
  • 11.2. Diagnostics & Therapeutics
  • 11.3. Drug Discovery & Clinical Research

12. Biobanking Market, by End User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutions
  • 12.3. Contract Research Organizations (CROs)
  • 12.4. Government & Public Health Agencies
  • 12.5. Hospitals & Clinical Labs
  • 12.6. Pharmaceutical & Biotech Companies

13. Americas Biobanking Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Biobanking Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Biobanking Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Avantor, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. ASKION GmbH
    • 16.3.4. Azenta Life Sciences, Inc.
    • 16.3.5. BioKryo
    • 16.3.6. BioLife Solutions, Inc.
    • 16.3.7. Charles River Laboratories International, Inc.
    • 16.3.8. Cryoport Systems, LLC
    • 16.3.9. Cureline, Inc.
    • 16.3.10. FIND
    • 16.3.11. Firalis Molecular Precision
    • 16.3.12. Greiner Bio-One International GmbH
    • 16.3.13. Hamilton Company
    • 16.3.14. LGC Biosearch Technologies
    • 16.3.15. Merck KGaA
    • 16.3.16. PHC Corporation
    • 16.3.17. Qiagen N.V.
    • 16.3.18. Sampled
    • 16.3.19. Sopachem BV
    • 16.3.20. SPT Labtech Ltd
    • 16.3.21. STEMCELL Technologies Inc.
    • 16.3.22. Taylor-Wharton
    • 16.3.23. Tecan Trading AG
    • 16.3.24. US Biolab Corporation, Inc.
    • 16.3.25. VigiSolvo

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. BIOBANKING MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOBANKING MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BIOBANKING MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOBANKING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOBANKING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. BIOBANKING MARKET: RESEARCHAI
  • FIGURE 26. BIOBANKING MARKET: RESEARCHSTATISTICS
  • FIGURE 27. BIOBANKING MARKET: RESEARCHCONTACTS
  • FIGURE 28. BIOBANKING MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKING MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOBANKING MARKET SIZE, BY AUTOMATED SAMPLE STORAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOBANKING MARKET SIZE, BY AUTOMATED SAMPLE STORAGE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOBANKING MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOBANKING MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOBANKING MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOBANKING MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TRANSPORT & PACKAGING UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TRANSPORT & PACKAGING UNITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOBANKING MARKET SIZE, BY CONSENT & REGULATORY COMPLIANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOBANKING MARKET SIZE, BY CONSENT & REGULATORY COMPLIANCE SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOBANKING MARKET SIZE, BY DATA MANAGEMENT & BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOBANKING MARKET SIZE, BY DATA MANAGEMENT & BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE COLLECTION & PROCESSING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE COLLECTION & PROCESSING SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE STORAGE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE STORAGE SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TRANSPORT & LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TRANSPORT & LOGISTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOBANKING MARKET SIZE, BY PHYSICAL BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOBANKING MARKET SIZE, BY PHYSICAL BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOBANKING MARKET SIZE, BY VIRTUAL BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOBANKING MARKET SIZE, BY VIRTUAL BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOBANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOBANKING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOBANKING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOBANKING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BIOBANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOBANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL BIOBANKING MARKET SIZE, BY CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOBANKING MARKET SIZE, BY CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL BIOBANKING MARKET SIZE, BY DNA/RNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOBANKING MARKET SIZE, BY DNA/RNA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL BIOBANKING MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOBANKING MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL BIOBANKING MARKET SIZE, BY DIAGNOSTICS & THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOBANKING MARKET SIZE, BY DIAGNOSTICS & THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL BIOBANKING MARKET SIZE, BY DRUG DISCOVERY & CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOBANKING MARKET SIZE, BY DRUG DISCOVERY & CLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL BIOBANKING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOBANKING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL BIOBANKING MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOBANKING MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL BIOBANKING MARKET SIZE, BY HOSPITALS & CLINICAL LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOBANKING MARKET SIZE, BY HOSPITALS & CLINICAL LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 265. FRANCE BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. FRANCE BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 271. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 273. FRANCE BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 283. RUSSIA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 289. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. RUSSIA BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. ITALY BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 299. ITALY BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 301. ITALY BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 303. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. ITALY BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 306. ITALY BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 307. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 309. ITALY BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 311. SPAIN BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 313. SPAIN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 315. SPAIN BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 317. SPAIN BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 319. SPAIN BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. SPAIN BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 321. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 323. SPAIN BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 324. SPAIN BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 325. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 327. SPAIN BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. SPAIN BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 331. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 333. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 335. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 337. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 339. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 341. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 343. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 345. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 348. SAUDI ARABIA BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 350. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 352. SAUDI ARABIA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 354. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 356. SAUDI ARABIA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 357. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 358. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 359. SAUDI ARABIA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 360. SAUDI ARABIA BIOBANKING MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 361. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 362. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 363. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 364. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 365. SOUTH AFRICA BIOBANKING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 366. SOUTH AFRICA BIOBANKING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 367. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 368. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 369. SOUTH AFRICA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 370. SOUTH AFRICA BIOBANKING MARKET SIZE, BY BIOBANKING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 371. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 372. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 373. SOUTH AFRICA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. SOUTH AFRICA BIOBANKING MARKET SIZE, BY BIOBANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 375. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)

TAB